Abstract
The history of fragment-based drug discovery, with an emphasis on crystallographic methods, is sketched, illuminating various contributions, including our own, which preceded the industrial development of the method. Subsequently, the creation of the BMSC fragment cocktails library is described. The BMSC collection currently comprises 68 cocktails of 10 compounds that are shape-wise diverse. The utility of these cocktails for initiating lead discovery in structure-based drug design has been explored by soaking numerous protein crystals obtained by our MSGPP (Medical Structural Genomics of Pathogenic Protozoa) consortium. Details of the fragment selection and cocktail design procedures, as well as examples of the successes obtained are given. The BMSC Fragment Cocktail recipes are available free of charge and are in use in over 20 academic labs.
Keywords: Structural genomics, drug design, malaria, trypanosomiasis, leishmaniasis, history
Current Topics in Medicinal Chemistry
Title: Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium
Volume: 9 Issue: 18
Author(s): Jonathan M. Caruthers, Wim G.J. Hol, Ethan A. Merritt, Frederick S. Buckner, Wesley C. Van Voorhis, Frank Zucker, Natasha Mueller, Angela Kelley, Alberto Napuli, Isolde LeTrong, Eric T. Larson, Christophe L.M.J. Verlinde, Jurgen Bosch, Tracy L. Arakaki, Liren Xiao, Jessica Kim, Jennifer Ross, Wei Deng, Zhihua Sun, Zhongsheng Zhang, Sayaka Shibata and Erkang Fan
Affiliation:
Keywords: Structural genomics, drug design, malaria, trypanosomiasis, leishmaniasis, history
Abstract: The history of fragment-based drug discovery, with an emphasis on crystallographic methods, is sketched, illuminating various contributions, including our own, which preceded the industrial development of the method. Subsequently, the creation of the BMSC fragment cocktails library is described. The BMSC collection currently comprises 68 cocktails of 10 compounds that are shape-wise diverse. The utility of these cocktails for initiating lead discovery in structure-based drug design has been explored by soaking numerous protein crystals obtained by our MSGPP (Medical Structural Genomics of Pathogenic Protozoa) consortium. Details of the fragment selection and cocktail design procedures, as well as examples of the successes obtained are given. The BMSC Fragment Cocktail recipes are available free of charge and are in use in over 20 academic labs.
Export Options
About this article
Cite this article as:
Caruthers M. Jonathan, Hol G.J. Wim, Merritt A. Ethan, Buckner S. Frederick, Van Voorhis C. Wesley, Zucker Frank, Mueller Natasha, Kelley Angela, Napuli Alberto, LeTrong Isolde, Larson T. Eric, Verlinde L.M.J. Christophe, Bosch Jurgen, Arakaki L. Tracy, Xiao Liren, Kim Jessica, Ross Jennifer, Deng Wei, Sun Zhihua, Zhang Zhongsheng, Shibata Sayaka and Fan Erkang, Fragment-Based Cocktail Crystallography by the Medical Structural Genomics of Pathogenic Protozoa Consortium, Current Topics in Medicinal Chemistry 2009; 9 (18) . https://dx.doi.org/10.2174/156802609790102383
DOI https://dx.doi.org/10.2174/156802609790102383 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of
COVID-19 Disease
Current Pharmaceutical Design Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry An Overview on Synthetic Methodologies and Biological Activities of Pyrazoloquinolines
Mini-Reviews in Medicinal Chemistry Recent Development of G-Quadruplex Probes for Cellular Imaging
Current Topics in Medicinal Chemistry Ezetimibe and other Azetidinone Cholesterol Absorption Inhibitors
Current Topics in Medicinal Chemistry Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Management of Food-Induced Anaphylaxis: Unsolved Challenges
Current Clinical Pharmacology Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction
Current Pharmaceutical Design SARS-CoV-2 Pandemic-Therapeutics in Warp Speed
Recent Advances in Anti-Infective Drug Discovery Anti-cancer Drug Development: Computational Strategies to Identify and Target Proteins Involved in Cancer Metabolism
Current Pharmaceutical Design Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells
Medicinal Chemistry Huntingtons Disease: The Value of Transcranial Meganetic Stimulation
Current Medicinal Chemistry A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Current Topics in Medicinal Chemistry Inhibitors of ER Aminopeptidase 1 and 2: From Design to Clinical Application
Current Medicinal Chemistry Effects of Drug Transporters on Pharmacological Responses and Safety
Current Drug Metabolism A Novel Functional Approach Toward Identifying Definitive Drug Targets
Current Medicinal Chemistry Descending Necrotizing Mediastinitis of Odontogenic Origin
Recent Patents on Anti-Infective Drug Discovery Inhibition of Anti-Apoptotic Bcl-2 Family Proteins by Natural Polyphenols New Avenues for Cancer Chemoprevention and Chemotherapy
Current Pharmaceutical Design Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design An Overview of Tetramethylpyrazine (Ligustrazine) and its Derivatives as Potent Anti-Alzheimer’s Disease Agents
Letters in Drug Design & Discovery